BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 37894746)

  • 1. The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis.
    Xu L; Yan X; Wang J; Zhao Y; Liu Q; Fu J; Shi X; Su J
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
    Meng F; Sun G; Zhong M; Yu Y; Brewer MA
    Int J Oncol; 2013 Aug; 43(2):495-502. PubMed ID: 23709006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of histone deacetylases (HDACs) in human cancer.
    Ropero S; Esteller M
    Mol Oncol; 2007 Jun; 1(1):19-25. PubMed ID: 19383284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
    Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y
    Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
    Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C
    Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications.
    Li Z; Zhu WG
    Int J Biol Sci; 2014; 10(7):757-70. PubMed ID: 25013383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Histone Deacetylases in Monocyte Function in Health and Chronic Inflammatory Diseases.
    Tordera RM; Cortés-Erice M
    Rev Physiol Biochem Pharmacol; 2021; 180():1-47. PubMed ID: 33974124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of HDACs--effective drugs against cancer?
    Müller S; Krämer OH
    Curr Cancer Drug Targets; 2010 Mar; 10(2):210-28. PubMed ID: 20201785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of HDACs in normal and malignant hematopoiesis.
    Wang P; Wang Z; Liu J
    Mol Cancer; 2020 Jan; 19(1):5. PubMed ID: 31910827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
    Rahimian A; Barati G; Mehrandish R; Mellati AA
    Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis.
    Zhao TC; Wang Z; Zhao TY
    Atherosclerosis; 2020 Jun; 303():36-42. PubMed ID: 32535412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential molecular mechanistic behavior of HDACs in cancer progression.
    Singh T; Kaur P; Singh P; Singh S; Munshi A
    Med Oncol; 2022 Aug; 39(11):171. PubMed ID: 35972597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors and cell death.
    Zhang J; Zhong Q
    Cell Mol Life Sci; 2014 Oct; 71(20):3885-901. PubMed ID: 24898083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylases function as novel potential therapeutic targets for cancer.
    Zhang H; Shang YP; Chen HY; Li J
    Hepatol Res; 2017 Feb; 47(2):149-159. PubMed ID: 27457249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma.
    Yang Q; Falahati A; Khosh A; Mohammed H; Kang W; Corachán A; Bariani MV; Boyer TG; Al-Hendy A
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of dietary histone deacetylases (HDACs) inhibitors in health and disease.
    Bassett SA; Barnett MP
    Nutrients; 2014 Oct; 6(10):4273-301. PubMed ID: 25322459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone Deacetylases (HDACs) in Gastric Cancer: An Update of their Emerging Prognostic and Therapeutic Role.
    Schizas D; Mastoraki A; Naar L; Tsilimigras DI; Katsaros I; Fragkiadaki V; Karachaliou GS; Arkadopoulos N; Liakakos T; Moris D
    Curr Med Chem; 2020; 27(36):6099-6111. PubMed ID: 31309879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer.
    Parbin S; Kar S; Shilpi A; Sengupta D; Deb M; Rath SK; Patra SK
    J Histochem Cytochem; 2014 Jan; 62(1):11-33. PubMed ID: 24051359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology.
    Patil RS; Maloney ME; Lucas R; Fulton DJR; Patel V; Bagi Z; Kovacs-Kasa A; Kovacs L; Su Y; Verin AD
    Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.